Independent Pharmacy Campaign

Pain Reliever Misuse Decreased by 11% in 2018

Pain Reliever Misuse Decreased by 11% in 2018

https://nabp.pharmacy/wp-content/uploads/2016/06/Kentucky-Newsletter-December-2019.pdf

NSDUH Survey IndicatesPrescription drug misuse, including abuse of stimulants and pain relievers, decreased in 2018, according to the recently released 2018 National Survey on Drug Use and Health (NSDUH). The annual survey, conducted by the Substance Abuse and Mental Health Services Administra-tion (SAMHSA), a division of HHS, is a primary resource for data on mental health and substance use, including abuse of prescription drugs, among Americans. Key findings of the 2018 NSDUH include: ♦Past-year abuse of psycotherapeutics decreased from6.6 from 6.2%.♦Past-year abuse of pain relievers decreased from 4.1%to 3.6%.♦Past-year abuse of stimulants decreased from 2.1%to 1.9%.♦Past-year abuse of opioids decreased from 4.2% to3.7%.“This year’s National Survey on Drug Use and Health contains very encouraging news:

The number of Americans misusing pain relievers dropped substantially, and fewer young adults are abusing heroin and other substances,” said HHS Secretary Alex Azar. “At the same time, many challenges remain, with millions of Americans not receiving treatment they need for substance abuse and mental illness.

Connecting Americans to evidence-based treatment, grounded in the best science we have, is and will remain a priority for President Donald Trump, for HHS, and for SAMHSA under Assistant Secretary Elinore McCance-Katz.” A recorded presentation of the data, along with a written summary and the full report are available on the SAMHSA website at https://www.samhsa.gov/data/nsduh/reports-detailed-tables-2018-NSDUH.Additional Efforts Needed to Improve Naloxone Access, CDC Says A new Vital Signs report published by the Centers for Disease Control and Prevention (CDC) states that naloxone dispensing has grown dramatically since 2012, with rates of naloxone prescriptions dispensed more than doubling from 2017 to 2018 alone. However, the rate of naloxone dispensed per high-dose opioid dispensed remains low, with just one naloxone prescription dispensed for every 69 high-dose opioid prescriptions.The researchers for the report examined dispensing data from IQVIA, a health care, data science, and technology company that maintains information on prescriptions from 50,400 retail pharmacies, representing 92% of all prescrip-tions in the US. According to their analysis, dispensing rates were higher for female recipients than for male recipients, and higher for persons aged 60-64 years than for any other age group. The researchers also found that the rate of nal-oxone prescriptions dispensed varied substantially across US counties, with rural and micropolitan counties more likely to have a low-dispensing rate. “Comprehensively addressing the opioid overdose epi-demic will require efforts to improve naloxone access and distribution in tandem with efforts to prevent initiation of opioid misuse, improve opioid prescribing, implement harm reduction strategies, promote linkage to medications for opioid use disorder treatment, and enhance public health and public safety partnerships,” the report states in its con-clusion. “Distribution of naloxone is a critical component of the public health response to the opioid overdose epidemic.”The Vital Signs report can be accessed at www.cdc.gov/mmwr/volumes/68/wr/mm6831e1.htm.

If you notice there is no mention of chronic pain pts getting any treatment

 

IV Tylenol As Good As Moose Urine For Post-Op Pain Control

IV Tylenol As Good As Moose Urine For Post-Op Pain Control

https://www.acsh.org/news/2019/12/02/iv-tylenol-good-moose-urine-post-op-pain-control-14429

Summary: In the mad dash to remove opioids from modern life, some researchers are willing to try anything, even Tylenol to control pain. How well does IV Tylenol work for post-operative pain from spinal surgery? Although the data are not complete it is safe to say that it’s no better than moose urine.

OK, I may have taken some license with the title but not with the science. Here’s the real title of a November 2019 paper in Pain Medicine News: ‘Post-op Pain Unaffected by IV Acetaminophen After Minimally Invasive Spine Surgery.” I prefer mine.

This is hardly the first time I have jumped ugly on Tylenol (acetaminophen). Aside from reducing children’s fevers and maybe working synergistically with Advil, there is no evidence that it is effective for treating any kind of pain (See Tylenol Isn’t So Safe, But At Least It Works, Right?) and plenty of evidence that it does nothing at all. 

What’s that part about it not being so safe? ACSH friend Dr. Aric Hausknect, a New York neurologist and pain management specialist suggests this in a not-so-subtle way. 

“Tylenol is by far the most dangerous drug ever made.”

Pain In The Time Of Opioid Denial: An Interview With Aric Hausknecht, M.D. 7/30/17

Yet, despite overwhelming evidence that Tylenol (acetaminophen) is an abject failure as a pain drug, hospitals and physicians, who are desperate to avoid opioid use no matter the circumstances, keep shoveling it into the mouths and veins of Americans. Just one of the many instances of medical insanity brought about by ignorant (or self-serving, you pick) edicts forced upon us by PROP (with generous help from “Clueless Tom” Frieden’s CDC) beginning roughly a decade ago. 

Speaking of PROP, don’t you think it’s time that they got a new image? These guys are all over the news and it’s getting stale. They need to re-brand. Here, I’ll help.

 

Original image: Iranian.com

Back to the Tylenol.

Let’s take a look at what we already know – that giving Tylenol for pain is a waste of the water it takes to swallow the pills and that giving it IV during or after surgery is ideologically-driven stupidity. 

“Although previous literature supports the benefit of including multimodal analgesia as part of an intraoperative pain management plan, our results failed to identify a measurable effect of perioperative acetaminophen alone on opioid requirements or pain scores.” 

Eugenia Ayrian, M.D., Keck School of Medicine of the University of Southern California 

Here are two non-surprises: 1) Tylenol doesn’t work; 2) When you see the term “multimodal” there’s a pretty good chance that you can substitute “a whole bunch of other crap that doesn’t work” and not be far off the mark.

“While intravenous acetaminophen may benefit a carefully selected subset of patients undergoing surgery, prospective carefully standardized studies need to be done to determine which patients will have the greatest benefit.”  (Also from Dr. Ayrian)

“Carefully selected subset?” Why does the following image come to mind? 

Photo: US Air Force Academy

According to the article, Dr. Ayrian and colleagues initiated a prospective randomized trial (first-rate) which somehow turned into a retrospective study (anything but first-rate) – no small feat. How did this happen? Prepare yourself.

The trial (187 patients) was supposed to compare pain levels of patients who underwent “minimally invasive” spinal surgery, for example, a discectomy, where the damaged part of a herniated or bulging disk is removed. Three groups were randomized: IV acetaminophen, oral acetaminophen, or neither. Then this happened (emphasis mine):

“However, due to the high cost of IV acetaminophen, a shortage of remifentanil and the disapproval of the research committee, the trial was stopped before completion.”

Do you see any problems here?

  1. The hospital can’t afford enough IV Tylenol for ~60 patients?? It costs 40 bucks for a 1,000 mg bottle. 
  2. They ran out of remifentanil, which, like fentanyl is used to maintain general anesthesia. What are they using instead? 

Is this the Keck School OR? Image: Viralnova.com

  1. I don’t know what they did to piss off the research committee but it must have been a doozie. This does not happen often.

Which gives me a chance to simultaneously endorse a really good movie while voicing some mild reservations about the hospital in question:

Ford vs Ferrari – excellent!   Keck School of Medicine – maybe not so much. Now we know why they were driving so fast.

HOW WELL DID THE IV TYLENOL WORK?

It didn’t.

Data from paper presented in graph form. Different dose forms, time interval… doesn’t matter. It made no difference whether surgical patients got Tylenol. None.

HOW WELL DOES MOOSE URINE WORK?

For those of you who are on the edge of your seats waiting to see the moose urine data, I must report with great sadness that, like the Keck School, we too suffered from logistical problems. In our case, it was a supply shortage. Estelle wasn’t up to the task.

 

 

Pharmacy workload puts patients at risk: union

Pharmacy workload puts patients at risk: union

http://www.thesuburban.com/news/city_news/pharmacy-workload-puts-patients-at-risk-union/article_5d6cc30a-bfe7-578c-86f7-620fcb3d7f57.html

More patients, budget cuts and lack of new hires are putting patients’ health at risk according to a survey of institutional pharmacy technicians conducted by the province’s largest health care workers union. The Federation of Health and Social Services (FSSS-CSN) unveiled the results which shows 88% of respondents report being constantly pressed for time due to a heavy workload.

There are 987 Senior Pharmacy Technician Assistants (ATSP) and Pharmacy Technical Assistants (ATP) in the public health and social services network who are responsible for preparing medicines in network facilities and must constantly adapt to new systems and technologies while being entrusted with more responsibilities.

“The weight that senior technical assistants in pharmacy have on their shoulders is shifting to services to the population. When a hospital pharmacy fails to respond to requests, patients wait longer and the risk of error increases, “says pharmacy technical assistant and regional union vice-president Marie-Line Séguin.

Respondents were near unanimous in noting that their work has become more demanding over time caused mostly by lack of staff, increase in patients and structural changes. Patients are increasingly put at risk of medication and transcription errors say 87% of respondents, with half of all technicians reporting delays in responding to requests from pharmacists and/or physicians.

Nearly three quarters reported having done overtime in the last six months and 79% say they went to work sick in the last 12 months, and 97% report that absent colleagues are not replaced. Workers say wage increases, increased staffing and continuing education are the leading solutions to the crisis.

Chicago police blame Facebook for illegal gun and drug sales

Chicago police blame Facebook for illegal gun and drug sales

https://www.staradvertiser.com/2019/12/03/breaking-news/chicago-police-blame-facebook-for-illegal-gun-drug-sales/

CHICAGO >> Private Facebook groups have “emboldened” sellers of illegal drugs and guns to connect with potential buyers over the social media site, Chicago police said today, as leaders announced that a two-year undercover investigation led to more than 50 arrests.

Police leaders, including Chicago’s new interim superintendent, also accused Facebook of failing to help prevent illegal sales of guns. The social media company banned private sales, trades and exchanges of firearms in 2016, but investigators said they found dealers using private groups and messages to quickly sell firearms and drugs at prices higher than street values.

First Deputy Superintendent Anthony Riccio said Facebook agreed to shut down groups identified during the Chicago investigation but that it also should kick members of those groups off the site.

“Facebook often cites privacy concerns when they are confronted with the facts of our investigation,” Riccio said. “The truth is, Facebook is harboring criminals. These criminals know how to use the privacy Facebook affords them and they profit from the sales of illegal drugs and dangerous guns.”

Riccio also said police have been frustrated by Facebook’s removal of fake profiles that investigators use to pose as potential buyers.

Facebook spokeswoman Sarah Pollack said the company quickly responds to “valid legal” requests from police.

“Illicit drug and firearms sales have no place on our platform,” Pollack said. “We remove content and accounts that violate our policy and catch over 97% of drug sale content and over 93% of the firearms sales content we remove before it is reported to us.”

The company’s instructions for law enforcement say a subpoena is required to share a subscriber’s records including name, email addresses and location information on recent log-ins; disclosing contents of an account requires a federal or state search warrant. The site also says all Facebook users must use “the name they go by in everyday life,” and fake accounts will be penalized.

Facebook says it uses detection technology to find content that violates its policies banning the sale of drugs or firearms, including posts in private groups.

Chicago police leaders have blasted Facebook after previous investigations of illegal guns and drug sales on the site. In 2017, then-Superintendent Eddie Johnson said the company was failing to cooperate with police cracking down on the activity.

Tension over law enforcement’s use of social media networks exists in other areas too; for example, police in Memphis were sued by the state’s branch of the American Civil Liberties Union in 2018 for using an undercover Facebook account to monitor protest groups’ activities.

Personal privacy advocates say Facebook could do more to protect users from that type of police activity and keep meeting its baseline responsibility to hold law enforcement to the same rules as everyone else on the platform.

“Police shouldn’t get to follow different rules than members of the public,” said Dave Maass, a researcher for the Electronic Frontier Foundation. “They may say ‘Oh, this is to cut down on gun sales.’ The next thing you know, you’re searching social media for information on First Amendment activities or whether they’ve been driving while texting.”

Charlie Beck, Chicago’s interim police superintendent and the former head of the Los Angeles Police Department, said Tuesday that Facebook users’ privacy rights don’t “trump the rights of the general public.”

“Another person’s rights have to stop where the safety of another individual becomes in jeopardy,” Beck said. “That’s what laws are all about.”

Dr. Thomas Kline, MD, PhD: Myth #3 ARE OPIATE PAIN MEDICATIONS (“opioids”) TOO DANGEROUS TO USE

Dr. Thomas Kline, MD, PhD: MYTH #2 Opiates don’t work for chronic pain

Chain pharmacies sue drugmakers, allege $2.8B in overcharges for diabetes med.. LAWSUIT CRISIS ?

Walgreens, Kroger sue drugmakers, allege $2.8B in overcharges for diabetes med

https://www.beckershospitalreview.com/pharmacy/walgreens-kroger-sue-drugmakers-allege-2-8b-in-overcharges-for-diabetes-med.html

Walgreens, Kroger and other retail pharmacy chains filed a lawsuit Dec. 2 against five drugmakers, alleging they participated in an antitrust scheme to dramatically hike the price of the diabetes drug Glumetza, according to Law360

The lawsuit is against brand-name drugmakers Bausch Health, Assertio, Salix and Santarus as well as generic drugmaker Lupin. Salix acquired Santarus for $2.6 billion in 2013. Bausch Health then acquired Salix for $14.5 billion in 2015.

According to the lawsuit, Assertio and Santarus entered into a pay-to-delay deal with Lupin in 2012 to ensure the generic drugmaker wouldn’t release a cheaper version of the diabetes drug until 2016.

The deal allegedly allowed the brand-name drugmakers to hike prices, leading to $2.8 billion in overcharges. The drugmakers increased the price of Glumetza from $350 to more than $3,000 for a 30-day supply within a four-month period, the lawsuit says. The price hikes allegedly caused $175 million in overcharges every year. 

Other, smaller retail chains have previously sued the drugmakers for the price hikes, according to Law360. 

Read the full article here

Faces of pain and the sound of silence

Medicare Advantage :you get what you pay for – OR – end up paying for what you get ?

Medicare Advantage Enrollees Discover Dirty Little Secret

https://www.medpagetoday.com/resource-centers/meeting-challenge-multiple-sclerosis/early-imaging-ms-may-predict-long-term-outcomes/2612

Getting out is a lot harder than getting in

Like many of the 22 million seniors now enrolled in Medicare Advantage (MA) plans, Tom Mills belatedly discovered its dirty little secret.

Also called Part C, these plans can cover a broad array of health services at low cost — that is, until one gets sick, at which point out-of-pocket costs can soar. But once in an MA plan, getting out can be even less affordable.

After Mills underwent a mitral valve repair and suffered a mild stroke with no lasting effects, the San Diego resident’s plan now charges him hundreds of dollars in monthly copays for drugs and other medical services. He had to pay $295 a night for his hospital stay.

But there was a much bigger shock. Mills, 71, learned that switching out of his MA plan will incur exorbitantly higher costs the next time he needs a serious medical intervention. If he moves to traditional Medicare and a prescription plan, he still needs a supplemental Medigap plan to pick up his 20% copays and deductibles.

Though the retired environmental geologist is training for his 57th half marathon, he now has a pre-existing condition.

Medigap plans in all but four states can and do reject people like him or require prohibitively higher premiums. Diabetes, heart disease, or even a knee replacement can be criteria for exclusion.

A health insurance broker told him no supplemental plan would cover him, and he’d be wasting his time if he applied.

No one told him about this side of MA when he enrolled at age 65. “You hear the pros, but nobody lists the cons.”

In the run-up to the Dec. 7 deadline to sign up for Medicare coverage, broadcast ads like one with Joe Namath tout Medicare Advantage’s array of services: dental as is described in this weblink, vision, hearing, gym membership, rides to medical appointments, doctor and nurse visits by phone, and even meal delivery and home aid. “Get what you deserve … at no additional cost,” Namath says. “Call now — it’s free.”

But some advocacy groups, including the American Medical Association (AMA), are pushing to mandate tighter plan rules and disclosure, with lists of network specialists. The AMA recently approved a resolution calling on the Centers for Medicare & Medicaid Services and other stakeholders, including the senior citizens’ lobby AARP, to make the process of choosing Medicare plans less confusing and more transparent.

A similar AMA resolution in 2018 declared that

“seniors are lured to these advantage plans by misinformation and confusing sales techniques,”

and that plan inadequacies result in “delay in nursing home placement for some members,” produce “poor service for some members … due to difficulties with physical therapy and rehab services. The number of days approved (for payment) has tended to be too short and the extent of rehab services too limited.”

Kevin Burke, MD, and Deepak Azad, MD, primary care doctors in Indiana, are members of the delegation that sponsored both resolutions.

“If your health is good, maybe these plans represent value for some patients, like providing gym memberships,” Burke said. “But that can change in the blink of an eye … with a stroke or an accident or some acute medical condition and they need a rehabilitation stay.” Then, services are restricted so much that “they can’t recover adequately from the stroke, or they bankrupt themselves staying another month to get a good recovery.”

Then they’re eligible for Medicaid, which pays doctors much less.

Burke and Azad think Medicare should not let people with serious health risks buy MA plans in the first place. And some critics say MA across the board is basically a scam.

‘Confusing’ Tools

Medicare.gov websites aren’t always clear about the process of transferring out of MA to traditional Medicare with a Medigap plan, but the general bottom line is that getting accepted by a Medigap plan is guaranteed only within the first 12 months after enrolling in Medicare at age 65.

MA plans, which are managed by private insurers, can be very complex, with the potential for substantial out-of-pocket costs when beneficiaries get sick played down. Medigap policies, which pay for many expenses not covered in basic Medicare, may cost more in monthly premiums up front, but once one is enrolled, premiums are set solely through “community rating” and beneficiaries’ age. New-onset health issues do not lead to premium increases.

The catch is that if one initially enrolls in an MA plan and then decides to switch out more than a year later, Medigap insurers will take into account the individual’s pre-existing conditions, and may decline coverage or demand high premiums.

The newly revised Medicare Plan Finder tool does not explain this possibility. Nor does another CMS website, “Join, switch, or drop a Medicare Advantage plan.”

A third Medicare.gov website, “When can I buy Medigap?” is more specific, explaining in the third section that “there’s no guarantee that an insurance company will sell you a Medigap policy if you don’t meet the medical underwriting requirements,” meaning the Medigap issuer’s stance on pre-existing conditions.

Yet another Medicare publication does explain that if beneficiaries enroll in a Medicare Advantage plan at age 65 and want to get out, they must do so within 1 year, and then they have another 63 days from the disenrollment date to buy a Medigap plan without risk of coverage denial or being subject to underwriting.

Other Complaints

Besides MA’s lack of transparency on costs, critics also cite problems with insurers’ provider networks. The AMA wants CMS to make sure networks are adequate and list physicians, their specialties and subspecialties, and how many actually cared for plan members the prior year.

AMA spokesman Robert Mills (no relation to Tom Mills) referenced a Kaiser Family Foundation report that found 35% of plans studied were served by a “narrow” physician network, meaning that fewer than 30% of the physicians in that county were contracted.

“Plans may purposefully understaff specialties to avoid attracting enrollees with expensive pre-existing conditions like cancer and mental illness,” he said.

David Lipschutz, an attorney with the Center for Medicare Advocacy in Washington, D.C., also hears about limitations. “It’s a common scenario,” he said. “Often you have to jump through certain hoops or over certain barriers to access care, or it’s subject to prior authorization.”

His colleague, attorney Toby Edelman, has heard beneficiaries complain about plans that have two nursing homes in their network. “There are 50 in your area, but they have two and these are not the best.”

At California’s Health Insurance Counseling and Advocacy Program, San Diego manager David Weil hears horror stories too. “If they answer yes [on a questionnaire] to something the company doesn’t like, the company won’t sell them a policy. Almost anything can be on their list.”

Why do people want to switch? Weil described it as a “funnel effect, the feeling that you have to squeeze through an ever-closing hole in order to get services … Or you have to wait eight weeks to see a specialist. People get fed up with that.”

Last month, veteran consumer advocate Ralph Nader blasted MA plans as nothing more than a way to enrich health insurers at seniors’ expense. Calling the plans “Medicare Disadvantage” and a “corporate trap,” Nader took the AARP, which offers its brand of Medicare Advantage through UnitedHealthcare, to task for being asleep on the issue, and in conflict because it gets a 4.95% commission.

AARP spokesman Gregory Phillips responded: “AARP supports increasing access through guaranteed issue to Medigap coverage, in addition to eliminating medical underwriting and age rating, to ensure that older Americans will get the coverage they need when they need it most.”

And he agreed that many beneficiaries may not be aware that plans “may terminate their relationship with Medicare in any given year; change the premiums, cost-sharing charges, or benefits from year to year (including drug coverage); and drop physicians from their networks during the year.”

“Beneficiaries may also not be aware that if they want to voluntarily leave an MA plan and return to traditional fee-for-service Medicare, they may be subject to medical underwriting for a Medicare supplement (Medigap) policy. This underwriting may result in their being refused a policy or being required to pay higher rates.”

But Phillips defended AARP’s participation in MA, saying it provides information on both MA and traditional Medicare plans.